A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals

Autor: Harinck, F., Konings, I.C., Kluijt, I., Poley, J.W., Hooft, J.E. van, Dullemen, H.M. van, Nio, C.Y., Krak, N.C., Hermans, J.J., Aalfs, C.M., Wagner, A., Sijmons, R.H., Biermann, K., Eijck, C.H. van, Gouma, D.J., Dijkgraaf, M.G., Fockens, P., Bruno, M.J., high-risk, i. Dutch research

Publikováno v: Gut, 65, 1505-13
Gut, 65(9), 1505-1513. BMJ PUBLISHING GROUP
Gut, 65, 9, pp. 1505-13
Gut, 65(9), 1505-1513. BMJ Publishing Group

Objective Endoscopic ultrasonography (EUS) and MRI are promising tests to detect precursors and early-stage pancreatic ductal adenocarcinoma (PDAC) in high-risk individuals (HRIs). It is unclear which screening technique is to be preferred. We aimed

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4e4d74893cfaa38db8f4cd7ee8f0fb1
https://hdl.handle.net/2066/165729

Gastric Adenocarcinoma in a 13-Year-Old Boy: a Diagnosis not Often Seen in This Age Group.

Autor: Raphael, M. F.¹ (AUTHOR) m.f.raphael@umcutrecht.nl, Kluijt, I.² (AUTHOR), Koot, B. G.³ (AUTHOR), Smets, A. M. J. B.⁴ (AUTHOR), Tilanus, M. E. C.⁵ (AUTHOR), Bras, J.⁶ (AUTHOR), van de Wetering, M. D.⁷ (AUTHOR)

Publikováno v: Pediatric Hematology & Oncology. Feb2011, Vol. 28 Issue 1, p71-77. 7p. 3 Color Photographs, 2 Black and White Photographs.

Is Early Diagnosis of Pancreatic Cancer Fiction? Surveillance of Individuals at High Risk for Pancreatic Cancer

Autor: Harinck, F., Poley, J.W., Kluijt, I., Fockens, P., Bruno, M.J., Hermans, J.J.

Publikováno v: Digestive Diseases, 28(4-5), 670-678. Karger
Digestive Diseases, 28, 4-5, pp. 670-8
Digestive Diseases, 28, 670-8
Digestive diseases (Basel, Switzerland), 28(4-5), 670-678. S. Karger AG

Pancreatic cancer represents one of the most deadly human malignancies with an overall 5-year survival of less than 5%. Despite improvements in imaging techniques and surgical techniques, survival statistics have hardly improved over the past decades

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c78fd8bfd1860c6cfe5553273363ece
https://hdl.handle.net/1765/21998

Het Bloom-syndroom in Nederland: Klinisch overzicht van een nationaal cohort

Autor: Hopman, S. M. J., Merks, J. H. M., Bijlsma, E. K., Boot, H., Knegt, A. C., Langenhorst, V., Schoenaker, M. H. D., Stuurman, K. E., Verheij, J. B. G. M., Wagner, A., Weemaes, C. M., Zwijnenburg, P. J. G., Michiels, E., Kluijt, I.

Publikováno v: Tijdschrift voor kindergeneeskunde, 81(6), 148-158. Bohn Stafleu van Loghum

Aim. To describe the clinical and molecular genetic characteristics of Bloom syndrome (BS) patients in the Netherlands, in comparison with the international Bloom syndrome cohort as described in the Bloom's Syndrome Registry (BSR). Patients. For this

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::64e56dd7aa412f9cbe3bd55ad1fb5eff
https://pure.amc.nl/en/publications/het-bloomsyndroom-in-nederland-klinisch-overzicht-van-een-nationaal-cohort(0388416e-3fd4-41d0-9edf-6dc5817b5fd7).html

Association of PHB 1630 C > T and MTHFR 677 C > T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study

Autor: Jakubowska, A., Rozkrut, D., Antoniou, A., Hamann, U., Scott, R.J., McGuffog, L., Healy, S., Sinilnikova, O.M., Rennert, G., Lejbkowicz, F., Flugelman, A., Andrulis, I.L., Glendon, G., Ozcelik, H., Thomassen, M., Paligo, M., Aretini, P., Kantala, J., Aroer, B., Wachenfeldt, A. von, Liljegren, A., Loman, N., Herbst, K., Kristoffersson, U., Rosenquist, R., Karlsson, P., Stenmark-Askmalm, M., Melin, B., Nathanson, K.L., Domchek, S.M., Byrski, T., Huzarski, T., Gronwald, J., Menkiszak, J., Cybulski, C., Serrano, P., Osorio, A., Cajal, T.R., Tsitlaidou, M., Benitez, J., Gilbert, M., Rookus, M., Aalfs, C.M., Kluijt, I., Boessenkool-Pape, J.L., Meijers-Heijboer, H.E.J., Oosterwijk, J.C., Asperen, C.J. van, Blok, M.J., Nelen, M.R., Ouweland, A.M.W. van den, Seynaeve, C., Luijt, R.B. van der, Devilee, P., Easton, D.F., Peock, S., Frost, D., Platte, R., Ellis, S.D., Fineberg, E., Evans, D.G., Lalloo, F., Eeles, R., Jacobs, C., Adlard, J., Davidson, R., Eccles, D., Cole, T., Cook, J., Godwin, A., Bove, B., Stoppa-Lyonnet, D., Caux-Moncoutier, V., Belotti, M., Tirapo, C., Mazoyer, S., Barjhoux, L., Boutry-Kryza, N., Pujol, P., Coupier, I., Peyrat, J.P., Vennin, P., Muller, D., Fricker, J.P., Venat-Bouvet, L., Johannsson, O., Isaacs, C., Schmutzler, R., Wappenschmidt, B., Meindl, A., Arnold, N., Varon-Mateeva, R., Niederacher, D., Sutter, C., Deissler, H., Preisler-Adams, S., Simard, J., Soucy, P., Durocher, F., Chenevix-Trench, G., Beesley, J., Chen, X., Rebbeck, T., Couch, F., Wang, X., Lindor, N., Fredericksen, Z., Pankratz, V.S., Peterlongo, P., Bonanni, B., Fortuzzi, S., Peissel, B., Szabo, C., Mai, P.L., Loud, J.T., Lubinski, J., OCGN, SWE BRCA, HEBON, EMBRACE, GEMO Study Collaborators, KConFab, CIMBA

Publikováno v: British Jounal of Cancer, 106(12), 2016-2024. Nature Publishing Group
Jakubowska, A, Rozkrut, D, Antoniou, A, Hamann, U, Scott, R J, McGuffog, L, Healy, S, Sinilnikova, O M, Rennert, G, Lejbkowicz, F, Flugelman, A, Andrulis, I L, Glendon, G, Ozcelik, H, Thomassen, M, Paligo, M, Aretini, P, Kantala, J, Aroer, B, von Wachenfeldt, A, Liljegren, A, Loman, N, Herbst, K, Kristoffersson, U, Rosenquist, R, Karlsson, P, Stenmark-Askmalm, M, Melin, B, Nathanson, K L, Domchek, S M, Byrski, T, Huzarski, T, Gronwald, J, Menkiszak, J, Cybulski, C, Serrano, P, Osorio, A, Cajal, T R, Tsitlaidou, M, Benítez, J, Gilbert, M, Rookus, M, Aalfs, C M, Kluijt, I, Boessenkool-Pape, J L, Meijers-Heijboer, H E J, Oosterwijk, J C, van Asperen, C J, Blok, M J, Nelen, M R & OCGN 2012, ' Association of PHB 1630 C >T and MTHFR 677 C >T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers : results from a multicenter study ', B J C, vol. 106, no. 12, pp. 2016-24 . https://doi.org/10.1038/bjc.2012.160
British Journal of Cancer, 106(12), 2016-2024
Jakubowska, A, Rozkrut, D, Antoniou, A, Hamann, U, Scott, R J, McGuffog, L, Healy, S, Sinilnikova, O M, Rennert, G, Lejbkowicz, F, Flugelman, A, Andrulis, I L, Glendon, G, Ozcelik, H, Thomassen, M, Paligo, M, Aretini, P, Kantala, J, Aroer, B, von Wachenfeldt, A, Liljegren, A, Loman, N, Herbst, K, Kristoffersson, U, Rosenquist, R, Karlsson, P, Stenmark-Askmalm, M, Melin, B, Nathanson, K L, Domchek, S M, Byrski, T, Huzarski, T, Gronwald, J, Menkiszak, J, Cybulski, C, Serrano, P, Osorio, A, Cajal, T R, Tsitlaidou, M, Benitez, J, Gilbert, M, Rookus, M, Aalfs, C M, Kluijt, I, Boessenkool-Pape, J L, Meijers-Heijboer, E J, Oosterwijk, J C, van Asperen, C J, Blok, M J, Nelen, M R, van den Ouweland, A M W, Seynaeve, C, van der Luijt, R B, Devilee, P, Easton, D F, Peock, S, Frost, D, Platte, R, Ellis, S D, Fineberg, E, Evans, D G, Lalloo, F, Eeles, R, Jacobs, C, Adlard, J, Davidson, R, Eccles, D, Cole, T, Cook, J, Godwin, A, Bove, B, Stoppa-Lyonnet, D, Caux-Moncoutier, V, Belotti, M, Tirapo, C, Mazoyer, S, Barjhoux, L, Boutry-Kryza, N, Pujol, P, Coupier, I, Peyrat, J P, Vennin, P, Muller, D, Fricker, J P, Venat-Bouvet, L, Johannsson, O, Isaacs, C, Schmutzler, R, Wappenschmidt, B, Meindl, A, Arnold, N, Varon-Mateeva, R, Niederacher, D, Sutter, C, Deissler, H, Preisler-Adams, S, Simard, J, Soucy, P & Durocher, F 2012, ' Association of PHB 1630 C > T and MTHFR 677 C > T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study ', British Journal of Cancer, vol. 106, no. 12, pp. 2016-2024 . https://doi.org/10.1038/bjc.2012.160
British Journal of Cancer
British journal of cancer, 106(12), 2016-2024. Nature Publishing Group
BRITISH JOURNAL OF CANCER
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
British Journal of Cancer, 106(12), 2016-2024. Nature Publishing Group
British Journal of Cancer, 106, 12, pp. 2016-24
British Journal of Cancer, 106, 2016-24

BACKGROUND: The variable penetrance of breast cancer in BRCA1/2 mutation carriers suggests that other genetic or environmental factors modify breast cancer risk. Two genes of special interest are prohibitin (PHB) and methylene-tetrahydrofolate reduct

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f429fd85dd45188d422b8924cf3e1a27
https://research.rug.nl/en/publications/95b5d040-9d86-40bf-8c87-8731292eb10a